pyrrolidonecarboxylic acid has been researched along with Diabetes Mellitus, Type 2 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, S; Bamba, T; Fukusaki, E; Furuno, M; Katakami, N; Matsuoka, TA; Omori, K; Shimomura, I; Takahara, M; Taya, N; Tsugawa, H | 1 |
| Chou, J; Li, Y; Liu, L; Liu, R; Liu, X; Sun, C; Yu, J; Zhao, X | 1 |
| Adelson, D; Ao, Y; Chen, A; Go, VL; Ko, M; Liu, YY; Marvizon, JC; Song, MK; Yang, H | 1 |
| Halmos, T; Suba, I | 1 |
| Igarashi, K; Yoshinari, O | 1 |
| Adelson, DW; Ao, Y; Chen, A; Go, VL; Nyby, MD; Smutko, V; Tuck, ML; Wijesuriya, J; Yang, H | 1 |
| Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; O'Harte, FP | 1 |
| Ao, Y; Go, VL; Song, MK; Toy, N; Yang, H | 1 |
| Bruce, CR; Carey, AL; Febbraio, MA; Hawley, JA; Pedersen, BK; Petersen, EW; Pilegaard, H; Southgate, RJ | 1 |
| Aas, AM; Birkeland, KI; Diep, LM; Seljeflot, I; Thorsby, PM; Torjesen, PA | 1 |
| Froguel, P; Lacquemant, C; Leprêtre, F; Vasseur, F | 1 |
| Daval, M; Ferré, P; Foufelle, F | 1 |
| Badaloo, V; Bennett, FI; Forrester, TE; Jackson, AA | 1 |
3 review(s) available for pyrrolidonecarboxylic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Role of the brain in the regulation of metabolism and energy expenditure: the central role of insulin, and insulin resistance of the brain].
Topics: Animals; Appetite Depressants; Appetite Regulation; Blood Glucose; Brain; Ceramides; Cognition; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hypothalamus; Incretins; Insulin; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Metabolic Syndrome; Neuropeptides; Non-alcoholic Fatty Liver Disease; Oligopeptides; Orexins; Pyrrolidonecarboxylic Acid | 2011 |
[Adipocytokins, obesity and development of type 2 diabetes].
Topics: Adiponectin; Adipose Tissue; Animals; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Incidence; Insect Hormones; Insulin Resistance; Leptin; Mice; Obesity; Oligopeptides; Pyrrolidonecarboxylic Acid; Resistin | 2005 |
[AMPK, an active player in the control of metabolism].
Topics: Adenylate Kinase; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Acids; Homeostasis; Humans; Insect Hormones; Insulin; Leptin; Models, Biological; Oligopeptides; Prevalence; Pyrrolidonecarboxylic Acid | 2006 |
1 trial(s) available for pyrrolidonecarboxylic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insect Hormones; Insulin; Life Style; Male; Middle Aged; Oligopeptides; Pyrrolidonecarboxylic Acid; Triglycerides | 2006 |
9 other study(ies) available for pyrrolidonecarboxylic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes.
Topics: Aged; Ankle Brachial Index; Biomarkers; Diabetes Mellitus, Type 2; Erythritol; Female; Gas Chromatography-Mass Spectrometry; Humans; Indican; Male; Mannitol; Metabolomics; Middle Aged; Peripheral Arterial Disease; Pyrrolidonecarboxylic Acid; Vascular Stiffness | 2020 |
Fasting serum α‑hydroxybutyrate and pyroglutamic acid as important metabolites for detecting isolated post-challenge diabetes based on organic acid profiles.
Topics: Biomarkers; Carboxylic Acids; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Hydroxybutyrates; Limit of Detection; Linear Models; Male; Metabolome; Middle Aged; Pyrrolidonecarboxylic Acid; Reproducibility of Results | 2018 |
Potent hyperglycemic and hyperinsulinemic effects of thyrotropin-releasing hormone microinjected into the rostroventrolateral medulla and abnormal responses in type 2 diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Hyperglycemia; Hyperinsulinism; Insulin; Male; Medulla Oblongata; Microinjections; Nerve Fibers; Neural Pathways; Protein Precursors; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Spinal Cord; Thyrotropin-Releasing Hormone; Vagus Nerve | 2010 |
Anti-diabetic effect of pyroglutamic acid in type 2 diabetic Goto-Kakizaki rats and KK-Ay mice.
Topics: Animals; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glucokinase; Glucose Intolerance; Glucose-6-Phosphatase; Hypoglycemic Agents; Male; Mice; Mice, Inbred Strains; Molecular Structure; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains | 2011 |
Role of brainstem thyrotropin-releasing hormone-triggered sympathetic overactivation in cardiovascular mortality in type 2 diabetic Goto-Kakizaki rats.
Topics: Adrenal Glands; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Glucose; Blood Pressure; Brain Stem; Cardiovascular Diseases; Cisterna Magna; Diabetes Mellitus, Type 2; Heart Rate; Inflammation; Injections; Irbesartan; Male; Myocardium; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Tetrazoles; Thyrotropin-Releasing Hormone; Vascular Cell Adhesion Molecule-1 | 2012 |
Degradation, insulin secretion, and antihyperglycemic actions of two palmitate-derivitized N-terminal pyroglutamyl analogues of glucose-dependent insulinotropic polypeptide.
Topics: Animals; Blood Glucose; Cell Line; Cricetinae; Cricetulus; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Gastric Inhibitory Polypeptide; Hypoglycemic Agents; Insulin; Insulin Secretion; Mice; Mice, Obese; Palmitates; Pyrrolidonecarboxylic Acid; Structure-Activity Relationship | 2005 |
Altered glucose and insulin responses to brain medullary thyrotropin-releasing hormone (TRH)-induced autonomic activation in type 2 diabetic Goto-Kakizaki rats.
Topics: Adrenalectomy; Animals; Autonomic Nervous System; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Injections, Intraventricular; Insulin; Male; Medulla Oblongata; Pancreas; Protein Isoforms; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; RNA, Messenger; Thyrotropin-Releasing Hormone; Vagotomy | 2005 |
Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion.
Topics: Adiponectin; Adipose Tissue; Biopsy; Diabetes Mellitus, Type 2; Gene Expression Regulation; Humans; Infusions, Intravenous; Insect Hormones; Interleukin-6; Male; Middle Aged; Muscle, Skeletal; Oligopeptides; Pyrrolidonecarboxylic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2006 |
Excessive excretion of 5-oxoproline and decreased levels of blood glutathione in type II diabetes mellitus.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Glutathione; Humans; Middle Aged; Pyrrolidonecarboxylic Acid; Regression Analysis | 1990 |